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Background: Peripheral pancytopenia is not a disease by itself; rather it describes simultaneous presence of
anemia, leucopenia and thrombocytopenia resulting from a number of disease processes. Only a few systematic
studies have been published on the topic of pancytopenia, although extensive studies have been done for its
different etiological factors like aplastic anemia, megaloblastic anemia, leukemia, etc. Thus, this study was carried
out to investigate for and to identify the causes of pancytopenia, to find out the frequency of different causes, to
determine the incidence of pancytopenia in relation to sex and age and to compare our findings with those of
other similar studies from this part of the world.
Methods: This was a prospective study conducted in the Department of Pathology of a teaching institute and a
tertiary care hospital in southern Maharashtra, India, over a period of two years. All the patients referred to the
central clinical laboratory for routine complete blood count (CBC) and peripheral smear (PS) examination, from
both - the outpatient and the inpatient departments, were screened for pancytopenia. Of these, a total number of
250 cases that fulfilled the diagnostic criteria were selected.
Detailed hematological investigations followed by bone marrow aspiration wherever indicated and possible were
performed according to standard methods to ascertain the causes of pancytopenia.
Results: A definite male preponderance was observed, the male to female ratio being 2.6 : 1. The majority of cases
were encountered in 3rd and 4th decades. Hypersplenism (29.2%), Infections (25.6%), Myelosuppressants (16.8%)
and Megaloblastosis (13.2%) were the four most common causes in this large series on pancytopenia from a single
centre in India.
Conclusion: Detailed clinical history and meticulous physical examination along with baseline hematological
investigations, provides invaluable information in the complete workup of pancytopenic patients, helping in
systematic planning of further investigations to diagnose and ascertain the cause, avoiding a battery of unnecessary
tests.
Keywords: Pancytopenia, Hypersplenism, Infections, Myelosuppressants, Megaloblastic anemia, Hypoplastic aplastic
anemia, Leukemia, Lymphoma, Plasma cell dyscrasia, Myelodysplastc syndrome* Correspondence: drarvind.jain@yahoo.com
ˆDeceased
1Laboratory Medicine Department, Imperial College London Diabetes Centre
(ICLDC), P.O. Box no. 222464, Al Ain, United Arab Emirates
Full list of author information is available at the end of the article
© 2013 Jain and Naniwadekar; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the
Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
Jain and Naniwadekar BMC Hematology 2013, 13:10 Page 2 of 9
http://biomedcentral.com/2052-1839/13/10Background
Peripheral pancytopenia is reduction in all three major
formed elements of blood to levels below their lower nor-
mal limit leading to simultaneous presence of anemia,
leucopenia and thrombocytopenia. Thus, it is not a disease
entity by itself, but rather a triad of findings [1].
It is a striking feature of many serious and life threaten-
ing illnesses and may be caused by several disorders ran-
ging from simple drug-induced bone marrow hypoplasia
and megaloblastic anemia to fatal aplastic anemia and leu-
kemias. The mechanism of development of pancytopenia
varies from decrease in hematopoietic cell production as
in aplastic anemia, trapping of normal cells in hypertro-
phied and overactive reticuloendothelial system as in
hypersplenism, ineffective hematopoiesis in megaloblasto-
sis or replacement by abnormal or malignant tissue in the
marrow [1,2].
Although pancytopenia is a relatively common hema-
tological entity and a serious clinical problem with ex-
haustive differential diagnoses, there is relatively little
discussion on this abnormality in major textbooks of
hematology and internal medicine [3].
A look at literature shows that there aren’t many com-
prehensive studies on this subject from developed world,
though extensive studies have been done for its individ-
ual etiological factors like aplastic anemia, megaloblastic
anemia, leukemia, myelodysplastic syndrome, etc. [4].
As the severity of pancytopenia and the underlying
pathology determines the management and prognosis of
these patients [4], identifying the correct etiopathology in
a given case is crucial and helps in implementing timely
and appropriate treatment. Thus, this study was conducted
mainly with the twin aims of diagnosing the patients with
pancytopenia and finding out the common disease entities
responsible for pancytopenia.
Methods
This prospective study was carried out over a period of
two years in the Department of Pathology, of a teaching
institute and a tertiary care hospital exclusively catering to
the rural population of southern Maharashtra state of
India. Approval from local ethical committee and institu-
tional review board of Krishna Institute of Medical
Sciences University (KIMSU) was obtained to conduct this
study. The institutional ethical committee did not feel that
written informed consent was required to conduct this
study and thus deemed it to be not applicable/waived.
All the patients referred to the central clinical labora-
tory of the hospital for routine complete blood count
(CBC) and peripheral smear (PS) examination, from the
outpatient and the inpatient departments were screened
for pancytopenia and a total number of 250 cases were
selected, based on the criteria’s defined by deGruchy [1]
as follows:1) Hemoglobin (Hb.) level – below 13.5 g/L for males
and below 11.5 g/L for females.
2) Total Leucocyte Count (TLC) - below 4 × 109/L.
3) Platelet (Plt.) count – below 150 × 109/L.
In all patients, a complete relevant medical history in-
cluding age, sex, smoking status, alcohol intake, history of
any treatment, intake of or exposure to potentially toxic
chemicals, agents or drugs, radiation exposure, history of
symptoms such as bone pains, fever, night sweats, malaise,
weight loss and pruritus was taken. A detailed meticulous
physical examination of every patient was done for pallor,
jaundice, hepatosplenomegaly, lymphadenopathy, sternal
tenderness and gum hypertrophy. Evidence of hypersplen-
ism and primary malignancy was searched for whenever
necessary. Basic hematological investigations like CBC,
reticulocyte count, and PS examination were performed in
each case.
Blood counts were done by semiautomated electronic
cell counter (Sysmex KX – 21, Transasia Biomedicals) and
were again crosschecked manually during PS examination.
Buffy coat preparation stained by leishman stain was used
wherever the TLC was markedly reduced. Bone marrow
aspiration studies using standard methods were done
wherever indicated and possible, avoiding the cases where
the cause for pancytopenia was obvious. In cases of failed
aspiration due to dry / bloody tap, insufficient cells, or
hypoplastic marrow, a bone marrow trephine biopsy was
done from anterior superior iliac spine using standard
methods.
Wherever indicated, other investigations performed in-
cluded erythrocyte sedimentation rate (ESR), urine and
stool examination, liver and renal function tests, serological
investigations for enteric fever, blood culture, ELISA for
HIV, hepatitis B and C viruses, chest and bone radiographs,
abdominal ultrasonography, urinary Bence Jones proteins
and serum electrophoresis; the investigative workup being
directed by the suspected underlying pathology and the
provisional diagnoses.
All the patients thus selected were investigated in a sys-
tematic manner, cause of pancytopenia was ascertained
and the data was analyzed on the basis of etiology, clinical
and hematological findings. Clinico-pathological correl-
ation was done in all cases before reaching a definitive
diagnosis.
Results
Of the 250 cases studied, 181 (72.4%) were males and 69
(27.6%) females (Figure 1). A definite male preponderance
was seen in the overall picture as well as in all age groups,
the overall male to female ratio being 2.6: 1. The age range
of patients in our study was 2 months to 95 years. The
maximum number i.e., 146 (58.4%) cases occurred below
the age of 40 years, with majority i.e., 109 (43.6%) cases
Age and Sex distribution of cases studied
Age Group (in 
years)
Male (M) Female 
(F)
Total no. Percentage
Below 1 year 3 - 3 1.2
1 – 10 9 6 15 6
11 – 20 11 8 19 7.6
21 – 30 37 16 53 21.2
31 – 40 40 16 56 22.4
41 – 50 27 7 34 13.6
51 – 60 26 8 34 13.6
61 – 70 19 5 24 9.6
71 – 80 6 2 8 3.2
81 – 90 2 1 3 1.2
91 – 100 1 - 1 0.4














































Figure 1 Age and sex distribution of cases studied.
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(22.4%) cases presented between 31 – 40 years of age mak-
ing it the commonest age group for presentation (Figure 1).
In this large series on pancytopenia from a single centre in
India, the most common cause was hypersplenism (29.2%)
followed by infections (25.6%), myelosuppressants (16.8%)
and megaloblastosis (13.2%) (Table 1).
Of the 73 (29.2%) cases of hypersplenism, 45 (61.6%)
cases were of congestive splenomegaly (Table 1), 36 cases
of which had signs of portal hypertension and the remai-
ning nine cases, were of congestive cardiac failure. Of the
36 cases of portal hypertension, 27 were known cases of
alcoholic liver cirrhosis, five suffered from hepatitis B in-
fection (HBsAg positive), two cases were diagnosed as
having cryptogenic liver cirrhosis and one case each of
portal cavernoma and splenic vein thrombosis.The second commonest cause of hypersplenism in
this series was malaria, n = 15 (20.5%) cases (Table 1),
of which seven were Plasmodium vivax positive, five
were Plasmodium falciparum positive and three had
mixed infection, of which one showed signs of dis-
seminated intravascular coagulation (DIC).
In the remaining 13 cases of hypersplenism, eight
(10.9%) were labeled as idiopathic, as no cause could be
found, three (4.2%) were diagnosed of having tropical
splenomegaly, and one case (1.4%) each of thalassemia
and Hodgkin’s lymphoma (Table 1).
Infections causing pancytopenia was the 2nd com-
monest cause of pancytopenia in our study accounting
for 64 (25.6%) cases. Known cases of AIDS was the com-
monest cause accounting for 30 (46.9%) cases followed
by patients admitted with septicemia, n = 14 (21.9%)
Table 1 Etiological breakup of 250 cases of pancytopenia
























Hypoplastic / Aplastic anemia 12 (4.8%)
Leukemia 7 (2.8%)
Lymphoma 2 (0.8%)
Plasma cell dyscrasia (PCD) 2 (0.8%)
Myelodysplastic syndrome (MDS) 1 (0.4%)
Miscellaneous 14 (5.6%)
Grand Total 250 (100%)
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additionally also suffering either from tuberculosis,
cryptococcal meningitis, pneumocystis carinii pneumo-
nia or hepatitis B infection.
Of the 14 cases of septicaemia, seven had gram–negative
sepsis (three with Kleibseilla, two with Pseudomonas and
two with Escherichia coli) and four had gram-positive
sepsis (two with Staphylococci and two with Streptococci).
In the remaining three patients no cause could be found
for their clinical presentation of septicaemia with pancyto-
penia. Of these 14 cases, 6 (42.8%) cases succumbed to
infection.
We had nine (14%) cases of enteric fever with pan-
cytopenia in this group (Table 1). All of them presented
as pyrexia of unknown origin (PUO); their CBC reports
showing varying degree of pancytopenia, no particularsignificant trend being observed. All of them showed sig-
nificantly positive widal test. One of the patients showed
resistance to Quinolones while other two developed
complications like acute psychosis and DIC.
Of the eight (12.5%) cases of tuberculosis in this group,
three cases were of pulmonary tuberculosis, two of abdom-
inal tuberculosis and one each of tuberculous osteomye-
litis, tuberculous meningitis and tuberculosis of chest wall.
We also had 3 patients in this group diagnosed to be suf-
fering from viral hepatitis but tests for hepatitis A, B & C
virus were negative.
The third cause for pancytopenia was the use of myelo-
suppressants accounting for total 42 (16.8%) cases, of
which 18 (42.8%) had either carcinoma (Table 1) of breast,
oral cavity, gastrointestinal tract, hypopharynx, cervix,
choriocarcinoma and were taking regular chemotherapy
and or radiotherapy.
Of the seven cases of leukemia on chemotherapeutic
agents, four (57%) cases were acute lymphoblastic leukemia
(ALL), two were chronic myeloid leukemia (CML) and one
case of acute myeloid leukemia (AML) - M4. Also, there
were five cases (11.9%) of Non-Hodgkin’s lymphoma
(NHL) and two cases (4.8%) of Hodgkin’s lymphoma in this
group (Table 1). Antineoplastic agents like Methotrexate,
Cyclophosphamide, Vincristine and 5-Flurouracil were used
in various combinations as per the regime used and pan-
cytopenia developed during the course of the therapy.
Of the 10 cases in others group, four cases were on
chronic use of analgesics for arthritis or spondylosis, two
cases were on Dapsone for leprosy, two on Neomercazole
for thyrotoxicosis and two on antiepileptics – Eptoin and
Carbamazepine each.
Of the 33 (13.2%) cases of megaloblastosis, 18 (54.5%)
cases showed pure megaloblastic anemia of varying sever-
ity whereas 15 (45.5%) cases showed dimorphic anemia
i.e., combination of iron deficiency and megaloblastic
anemia in varying proportions, the megaloblastic change
being partially masked by the superadded iron deficiency.
Of the 12 (4.8%) cases in hypoplastic / aplastic anemia
group, eight cases were of hypoplastic anemia and four of
aplastic anemia, as established by bone marrow findings. Of
the eight cases of hypoplastic anemia, one case had a his-
tory of viral hepatitis a month preceding his pancytopenia
and one case was HIV positive. Of the four cases of aplastic
anemia, one case had history of chronic alcoholism and one
patient had a thymoma removed (operatively). In the
remaining 8 (66.7%) cases, no cause for hypoplasia or aplasia
could be identified and so were labeled as idiopathic.
Of the seven (2.8%) cases in leukemia group, four
cases were ALL and three were AML (two cases of M3
and one of M1).
Of the 14 cases in the miscellaneous group, two were
pregnant women, two had a history of passing worms,
one was a known case of malabsorption syndrome, one
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amoebiasis, pancreatitis and chronic renal failure. All the
cases showed a dimorphic blood picture and so the pan-
cytopenia was thought to be due to nutritional defi-
ciency of Iron, Vitamin B12 and Folic acid, once again
hinting towards the higher prevalence of nutritional ane-
mia’s in Indian subjects especially in rural population. As
these patients did not turn up again after their first visit,
further investigations to find the cause of pancytopenia
could not be done.
Discussion
The variation in the frequency of various diagnostic entities
causing pancytopenia in different population groups
(Table 2) has been attributed to differences in methodology
and stringency of diagnostic criteria, period of observation,Table 2 Comparison of number of cases, age and sex distribu
different studies conducted in different countries







Kale P et al.[6] India 1991 70 All - HS
Tilak and Jain
et al.[4] India 1999 77 5 to 70 1.1 : 1 MA
Savage et al.[7] Zimbabwe 1999 134 All -
Kumar et al.[5] India 2001 166 12 - 73 2.1 : 1 AA
Iqbal W et al.[8] Pakistan 2001 208 All - MA
Khunger et al.[9] India 2002 200 2 - 70 1.2 : 1 MA
Niazi M. et al.
[10] Pakistan 2004 89 1 - 75 1.7 : 1
BM
(3
Ishtiaq O et al.
[3] Pakistan 2004 100 12 - 82 1.1 : 1 MA
Hamid et al. [11] Yemen 2008 75 3 - 85 1.03 : 1 HS
P. M. devi et al.
[12] India 2008 50 3 - 80 1.5 : 1 HA
Jalbani A. et al.
[13] Pakistan 2009 40 12 - 70 2.6 : 1 AA
Tariq M. et al.
[14] Pakistan 2010 50 15 - 70 1.7 : 1 AA
Santra G. et al.
[15] India 2010 111 13 - 65 1.5 : 1 AA
Aziz T. et al.[16] Pakistan 2010 88 15 - 60 2.6 : 1 MA
Ashraf S. et al.
[17] Pakistan 2010 150 15 - 60 1.1 : 1 HS
Gayathri B. N.
et al.[18] India 2011 104 2 - 80 1.2 : 1 MA
Vandana R. et al.
[19] India 2012 80 1 - 79 1 : 1.2 MA
Present study India 250 All 2.6 : 1 HS
HS: Hypersplenism; MA: Megaloblastic anemia; AA: Aplastic Anemia; AL: Acute leuke
KA: Kala-azar; CM: Chronic malaria; HM: Hypoplastic marrow; NHL: Non-Hodgkin’s ly
DA: Dimorphic Anemia.geographic area, age pattern, nutritional status, prevalence
of infective disorders, genetic differences, and varying ex-
posure to myelotoxic agents amongst other factors [5].
A definite male predominance observed in our study
has been reported by many other similar studies (Table 2),
which could be due to social / cultural taboos in our
society, making health care facilities more readily available
to males as compared to females leading to increased male
presentation at hospitals especially in rural areas.
In our study, majority n = 109 (43.6%) cases presented in
3rd and 4th decade (Figure 1) which included maximum
number of cases in the major causes of pancytopenia
i.e. 35 (47.9%) cases in hypersplenism group, 40 (62.5%)
cases in the infections group and 17 (51.5%) cases in
megaloblastosis group (Table 3), explaining the finding.




cause 3rd common cause 4th common cause
(47.6%) MA (25.4%) AL (14.5%) Infections (7.25%)
(68%) AA (7.7%) Other causes (24.3%)












MA (24.7%) HS (18.4%) AL (13.6%)
(39%) HS (19%) AA and HA (10%) MDS (5%)
(45.3%) MA (14.7%) AA (13.3%) AL (13.3%)
(22%) MA (18%) MDS (18%)
Subleukemic
leukemia (14%)
(32.5%) HS (22.5%) MA (15%) NHL (10%)
(36%) MA (16%) MDS (14%) ALL (12%)
(22.72%) HS (15%) DI (13%) KA (9%)
(40.9%) AA (31.9%) HS and CM (11.4%) AL (10%)












mia; HA: Hypoplastic anemia; BM: Bone marrow; DI: Drug induced;
mphoma; MDS: Myelodysplastic syndrome; ALL: Acute lymphoblastic leukemia;






Hypersplenism Infections Myelosuppressants Megaloblastosis HA/
AA
Leukemia Lymphoma PCD MDS Miscellaneous Total
Below
1 year
- 3 - - - - - - - - 3
1 – 10 1 3 5 - 3 3 - - - - 15
11 – 20 6 3 2 4 3 1 - - - - 19
21 – 30 15 22 3 6 - 1 - - - 6 53
31 – 40 20 18 2 11 3 - - - - 2 56
41 – 50 12 6 6 6 1 2 - - - 1 34
51 – 60 11 3 12 2 - - 2 2 1 11 34
61 - 70 6 5 8 2 1 - - - - 2 24
71 – 80 1 1 4 1 1 - - - - - 8
81 - 90 1 - - 1 - - - - - 1 3
91 -
100
- - - - - - - - - 1 1
Total 73 64 42 33 12 7 2 2 1 14 250
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penia [12,14,15].
The commonest cause of pancytopenia in the present
study was hypersplenism (29.2%) whereas in other simi-
lar studies the incidence varies from 3 to 68% (Table 2).
We think that this may be due to the increasing trend of
chronic alcoholism in today’s society; hence more and
more patients present with chronic liver disease and de-
compensated liver cirrhosis, hypersplenism being one of
the consequences.
In hypersplenism there is peripheral pooling or trap-
ping and destruction of cells in an enlarged spleen
resulting in cytopenias. Increasing severity of the condi-
tion causes pancytopenia, as is seen in patients with
chronic liver disease and thus hypersplenism may come
out to be a common cause for pancytopenia [17,18,20].
Increase in incidence of hypersplenism in our study
may also be related to the increased prevalence of
malaria, kala azar and other infectious diseases in India,
malaria in particular being endemic, especially in the
state of Maharashtra. Thus, the incidence of pancyto-
penia due to hypersplenism caused by parasitic infec-
tions is subject to enormous geographical variation. In
tropical countries, the incidence is as high as the fre-
quency of splenic enlargement caused by tropical para-
sitic infections: malaria, leishmaniasis, brucellosis, and
schistosomiasis [11].
Malaria, especially Plasmodium falciparum, may cause
pancytopenia as a result of hypersplenism, immune
hemolysis, DIC, bone marrow necrosis, hemophagocytosis,
impairment of marrow function, or direct bone marrow in-
vasion by the parasite. Hamid et al. reported hypersplenism(28%) and malaria (17.3%) to be the two most common
causes of pancytopenia contributing for more than 45% of
cases in his study of 75 pancytopenic patients [11].
Some of the other studies also found malaria to be a
common cause for pancytopenia but did not group mal-
arial infestation under hypersplenism, which is the case
in our study [4,5,10,16]. Our findings are consistent with
theirs even if malarial infestation as such is considered
as a separate cause of pancytopenia without considering
the effects of ensuing hypersplenism. All the patients of
malaria related pancytopenia in our study made comp-
lete hematological and clinical recovery after appropriate
treatment.
Though only three (4.2%) cases were diagnosed as
Tropical splenomegaly in this group, this figure could be
still higher and a major bulk of idiopathic cases may turn
out to be tropical splenomegaly, if detailed investigations
like measuring malaria antibody levels, seeing for clinical
and immunological response to antimalarials etc., are
undertaken as outlined by Fankule, as malaria is endemic
in India [21].
Infections causing pancytopenia was the 2nd commonest
cause of pancytopenia, n = 64 (25.6%) cases in our study. Of
these, the majority were patients suffering from AIDS n =
30 (46.9%) cases and septicemia n = 14 (21.9%) cases. HIV
infection and overwhelming bacterial infections are known
to cause various hematological manifestations including
pancytopenia. Savage et al. reported AIDS to be the third
most common cause of pancytopenia in his study of 134
hospitalized pancytopenic patients in Zimbabwe [7]. Devi
P. M. et al. also found 6% of pancytopenia cases due to
HIV infection in her study of 50 cases [12].
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most of them are in Sub-Saharan Africa and South East
Asia. Profound hematological abnormalities are amongst
the commonest and maybe the first clinico-hematological
manifestations of HIV infection and AIDS, involving all
cell lineages of blood. Hematological manifestations are
diverse and common throughout the course of HIV infec-
tion and maybe attributable to the direct and indirect
effects of HIV infection, opportunistic infections and neo-
plasms, and side effects of therapy. Cytopenias are the
most frequent of these abnormalities and the frequency
and severity of cytopenias increase in the advanced
stages of the disease. Anemia is the most common cyto-
penia, others being granulocytopenia with or without
lymphopenia and thrombocytopenia [22,23].
Of the 14 cases of septicemia due to various infections,
two patients showed signs of DIC and one showed evidence
of bone marrow necrosis on marrow aspiration. Similar
studies showed the rate of pancytopenia due to severe
chronic infections to range between 4 – 9% [3,6,8], but the
details of the various types of infections was not available
for comparison.
We had nine (14%) cases of enteric fever with pancyto-
penia in this group (Table 1), all of them recovered from
the infection uneventfully after appropriate treatment in-
dicating that peripheral blood changes in general and the
pancytopenia in specific did not influence the outcome of
the disease as suggested by James J et al. [24].
Typhoid fever, which continues to be a major public
health problem in countries like India despite the im-
provements in living standards, has shown changing
modes of presentation and complications over the last few
years. Though leucopenia with or without neutropenia are
characteristic hematological findings; its association with
pancytopenia has been reported infrequently in English
literature [25]. Development of pancytopenia in enteric
fever has been attributed to bone marrow suppression, ne-
crosis, infection associated hemophagocytic syndrome,
disseminated intravascular coagulation and development
of septicemic complications [26].
All of the eight (12.5%) cases of tuberculosis in this
group, had presenting symptoms of fever and weight
loss and were put on Anti-Koch’s therapy (AKT), pancy-
topenic presentation being after a varying duration of
2 – 4 months.
Tuberculosis is a common disease in India and in
many other countries. Miliary (disseminated) tubercu-
losis is known to cause pancytopenia and there are
sporadic reports of pulmonary tuberculosis too caus-
ing pancytopenia. Although pancytopenia appears to
be a rare presentation of tuberculosis, it is advised to
always consider tuberculosis as differential diagnosis
in patients presenting with pancytopenia, unexplained
pyrexia and weight loss. Degree of pancytopenia isinfluenced more by duration of infection than by its
severity [27,28].
The pathogenesis of pancytopenia in tuberculosis has
intrigued both physicians and pathologists for years, the
exact pathogenesis being not known [28]. Numerous
hypotheses have been put forward to explain the occur-
rence of pancytopenia in tuberculosis and both the
tubercle bacilli as well as the AKT have been implicated
in its pathogenesis [29]. It has also been suggested by
Glasser et al. that other causes of pancytopenia must be
diligently sought for in these patients [30]. Other causes
of pancytopenia were excluded on clinical and laboratory
evaluation in our cases.
All said and done, when tuberculosis occurs with pan-
cytopenia, the mortality rate is high despite of anti-
tuberculosis treatment although there are a few reports
claiming recovery for their patients [28]. Considering
that tuberculosis is a common disease in countries like
India, the number of patients who are taking AKT at any
particular time and the number of patients who are initi-
ated on AKT in a year, there remains an immense po-
tential for the occurrence of blood dyscrasias including
pancytopenia in such patients.
Thus, the physicians should remain alert to the fact
that these may be caused by the disease itself or by the
drugs when on AKT and so should have a high index of
suspicion paving way for early detection and interven-
tion leading to overall reduction in morbidity and mor-
tality in these patients [31].
We also had 3 patients in this group presenting with
fever, jaundice and pain in the hypochondriac region with
deranged liver function tests, diagnosed to be suffering
from viral hepatitis but tests for hepatitis A, B & C virus
were negative. CBC reports of these patients showed
moderate pancytopenia with normocytic normochromic
anemia and normal reticulocyte count.
Pancytopenia with or without aplastic marrow has
been reported with increasing frequency in association
with variety of viral illnesses, especially infectious hepa-
titis. Viral hepatitis has been known to cause transient
pancytopenia during the course of illness and has also
been associated with aplastic anemia, virus of unidenti-
fied types being the most common ones. Hepatitis asso-
ciated pancytopenia and aplastic anemia are usually fatal
with a mortality rate as high as 85% [32].
Few other studies too have reported infections like
septicemia, enteric fever, tuberculosis, HIV etc. as in-
dependent causes of pancytopenia without integrating
them together under “infections” group, as is done in
our study [3,4,7,9,12,13,15].
Relative to other studies, the overall incidence of infec-
tions causing pancytopenia appears to be high in our
study. The likely explanation being that our hospital, as
a tertiary care centre caters to the poor rural population
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ness is suboptimal. Thus, patients frequently arrive in
hospital after considerable delay, with advanced disease
and overwhelming widespread infections, which are dif-
ficult to control even with advanced therapy, as is evi-
dent from the 42.8% mortality rate in these septicemic
patients.
Use of myelosuppressants was the 3rd most common
cause for pancytopenia in our study accounting for a total
of 42 (16.8%) cases. Patients developing pancytopenia sec-
ondary to myelotoxic chemotherapy for hematologic or
other malignancies were excluded in few of the studies,
causing a selection bias between our and their study
[3,5,11,14,16,18]. Santra G. et al. reported 13.5% cases of
pancytopenia secondary to chronic use of drugs including
chemotherapy in their study of 111 patients, which is
comparable to ours [15].
Our institute has separate oncosurgery and radiotherapy
units considered as a regional referral centre, more so for
carcinoma of breast and oral malignancies which accounted
for 18 (42.8%) out of 42 cases in this group. Chemo and
radiotherapy cycles are known to cause pancytopenia due
to bone marrow suppression, which is considered as an ex-
tension of the therapeutic effect, such complications being
a part of the natural course of the therapy for the disease
and were not an unexpected finding in our study.
Megaloblastic anemia and hypoplastic/aplastic anemia
were the 4th and 5th most common causes of pancyto-
penia, accounting for 33 (13.2%) and 12 (4.8%) cases re-
spectively. The commonest cause of pancytopenia reported
in majority of the studies from various parts of the world
has been megaloblastic anemia or hypoplastic/aplastic
anemia (Table 2), which is in sharp contrast with the results
of our study. However, the incidence of megaloblastic
anemia and hypoplastic/aplastic anemia in other studies
varies from 0.8 to 74% and 7.7 to 52.7% respectively
(Table 2) and our findings are still comparable.
Diagnosis of megaloblastosis in this study was estab-
lished by bone marrow findings and further estimation of
folic acid and vitamin B12 levels was not performed. The
exact cause of deficiency of these vitamins was also not de-
tected, as further tests to determine the etiology are diffi-
cult and expensive to perform in most instances. Thus, all
the patients in this group were treated with both folic acid
and parenteral hydroxycobalamin therapy, with complete
documented clinical and hematological recovery in all.
Of the seven (2.8%) cases in leukemia group, four cases
were ALL and three were AML (two cases of M3 and one
of M1). The incidence of acute/subleukemic leukemia in
other similar studies varies from 1.8 to 14.5% (Table 2).
Whilst ALL in childhood is the most common association,
pancytopenia preceding AML has been described in the
literature and adults are occasionally known to be affected
[5,8,12,14].We had 2 (0.8%) cases of NHL with evidence of bone
marrow involvement but no splenomegaly and were not
on myelosuppressants at the time of pancytopenic pres-
entation. NHL is known to infiltrate bone marrow more
commonly than Hodgkin’s disease and thus leading to
pancytopenia [2]. The incidence of NHL in other similar
studies varies from 0.9 to 10% (Table 2).
We found 2 (0.8%) cases of plasma cell dyscrasia pre-
senting as pancytopenia. Similar other studies too have
reported multiple myeloma presenting as pancytopenia,
the incidence varying from 0.9 to 4% (Table 2).
We also found a single (0.4%) case of pancytopenia due
to MDS of Refractory Anemia with Excessive Blasts
(RAEB) type. The incidence of MDS as reported in other
similar studies varies from 0 to 18% (Table 2). MDS are
most common in the elderly and should be included in
the differential diagnosis of elderly patients with pancyto-
penia, even if mild. Pancytopenic presentation is more
common with MDS-RAEB type [9,20].Conclusions
Hypersplenism due to decompensated alcoholic liver cir-
rhosis and infections like HIV and tuberculosis are on
rise in today’s society, more so in this part of the world
and hence should be kept in mind as causes for pancyto-
penic presentation.
Anti-neoplastic therapy cycles are known to cause
pancytopenia due to myelosuppression and so these haz-
ardous therapies should not be used without facility for
regular follow-up and supervision.
Enteric fever, malaria, tuberculosis, megaloblastic
anemia are relatively benign, easily treatable and re-
versible causes of pancytopenia and thus have a good
prognosis. Their early diagnosis is important to pre-
vent further complications.
Overwhelming bacterial infections and septicemia as a
cause of pancytopenic presentation particularly in the
developing countries should always be kept in mind.
Early and aggressive treatment initiation should be a pri-
ority in these patients, as if left untreated the prognosis
is bad.
Detailed clinical history and meticulous physical exam-
ination along with baseline hematological investigations
provide invaluable information in the evaluation of pan-
cytopenic patients, helping in systematic planning of fur-
ther investigations to diagnose and ascertain the cause,
avoiding unnecessary tests which not only add to the ex-
pense of treatment but sometimes also may result in de-
layed diagnoses and treatment.
As a large proportion of causes for pancytopenia are
treatable and reversible, accurate diagnoses and timely
intervention maybe lifesaving and will certainly have im-
pact on the morbidity and mortality in these vulnerable
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specific and timely treatment and for prognostication.
As the etiologies of pancytopenia are varied, so is the
prognosis. In our study majority of the cases had a treat-
able cause and so carried better prognosis.
General physicians who are not hematologists are un-
likely to be as well versed in the specific constellation of
findings that characterize individual hematologic entities.
Stringent diagnostic criteria and a general conceptual
framework for ascertaining the cause of pancytopenia is
therefore very valuable and a demand of time.
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